Fusion Pharmaceuticals Inc (FUSN)
21.46
-0.02
(-0.08%)
USD |
NASDAQ |
May 03, 14:16
Fusion Pharmaceuticals Total Return Level: 21.47 for May 2, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 02, 2024 | 21.47 |
May 01, 2024 | 21.42 |
April 30, 2024 | 21.43 |
April 29, 2024 | 21.40 |
April 26, 2024 | 21.42 |
April 25, 2024 | 21.40 |
April 24, 2024 | 21.40 |
April 23, 2024 | 21.42 |
April 22, 2024 | 21.32 |
April 19, 2024 | 21.26 |
April 18, 2024 | 21.25 |
April 17, 2024 | 21.24 |
April 16, 2024 | 21.26 |
April 15, 2024 | 21.28 |
April 12, 2024 | 21.31 |
April 11, 2024 | 21.36 |
April 10, 2024 | 21.36 |
April 09, 2024 | 21.38 |
April 08, 2024 | 21.40 |
April 05, 2024 | 21.32 |
April 04, 2024 | 21.43 |
April 03, 2024 | 21.34 |
April 02, 2024 | 21.29 |
April 01, 2024 | 21.25 |
March 28, 2024 | 21.32 |
Date | Value |
---|---|
March 27, 2024 | 21.30 |
March 26, 2024 | 21.30 |
March 25, 2024 | 21.18 |
March 22, 2024 | 21.24 |
March 21, 2024 | 21.20 |
March 20, 2024 | 21.09 |
March 19, 2024 | 21.18 |
March 18, 2024 | 10.64 |
March 15, 2024 | 9.99 |
March 14, 2024 | 9.34 |
March 13, 2024 | 9.50 |
March 12, 2024 | 9.48 |
March 11, 2024 | 9.42 |
March 08, 2024 | 10.04 |
March 07, 2024 | 10.03 |
March 06, 2024 | 9.90 |
March 05, 2024 | 10.50 |
March 04, 2024 | 10.79 |
March 01, 2024 | 11.99 |
February 29, 2024 | 11.96 |
February 28, 2024 | 12.20 |
February 27, 2024 | 12.50 |
February 26, 2024 | 12.65 |
February 23, 2024 | 12.14 |
February 22, 2024 | 13.05 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.98
Minimum
Nov 07 2022
21.47
Maximum
May 02 2024
7.468
Average
7.03
Median
Mar 15 2022
Total Return Level Benchmarks
AstraZeneca PLC | 217.05 |
Landos Biopharma Inc | 22.25 |
Acasti Pharma Inc | 3.03 |
Aurinia Pharmaceuticals Inc | 5.16 |
Edesa Biotech Inc | 4.555 |